tiprankstipranks
Trending News
More News >
Amcor PLC (AMCR)
NYSE:AMCR

Amcor (AMCR) AI Stock Analysis

Compare
1,530 Followers

Top Page

AMCR

Amcor

(NYSE:AMCR)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
$52.00
▲(7.37% Upside)
Action:ReiteratedDate:02/05/26
AMCR’s score is driven primarily by improving revenue and strong free cash flow generation, but held back by meaningful margin compression and a moderately leveraged balance sheet. Technically, the trend is positive but appears overbought, while valuation is mixed (high P/E offset by a strong dividend). Earnings-call guidance and synergy progress are supportive, though volume softness and non-core underperformance remain notable risks.
Positive Factors
Free cash flow generation
Amcor’s sustained FCF (~$1.62B TTM) and free-cash-flow-to-net-income ~1.01x indicate durable cash conversion quality. Reliable FCF supports capex, dividends, debt paydown and funding of integration costs over the medium term, underpinning financial flexibility.
Improving revenue momentum
Top-line growth (+12.7% TTM) reflects successful scale gains from acquisitions and commercial wins. Durable revenue momentum across core businesses provides a larger base to recover margins and fund investments, making long-term earnings recovery more feasible even if volumes fluctuate.
Synergy capture & integration
Accelerating synergy realization (YTD $93M; FY26 ≥$260M; $650M to 2028) shows execution on merger economics. Sustained synergy delivery can structurally improve margins, free cash flow and ROI, supporting deleveraging and long-term margin recovery beyond short-term integration costs.
Negative Factors
Margin compression
Material margin erosion (TTM net margin ~3.3% vs prior ~5.4%–7.1%) signals weaker earnings efficiency. Persistently lower margins reduce internal reinvestment capacity and ROE, requiring sustained operational fixes and realized synergies to restore profitability over the medium term.
Meaningful leverage
A moderately leveraged balance sheet (D/E ~1.3x, adjusted leverage cited higher in quarterly commentary) limits flexibility in a higher-rate environment. Elevated leverage increases sensitivity to cash flow swings and constrains strategic options until deleveraging targets are met.
Non-core weakness & volume decline
Underperformance in a ~$2.5B non-core portfolio and company volumes down ~2%–2.5% indicate structural demand softness and portfolio drag. Persistent weak volumes and low-margin non-core assets can depress consolidated margins and require portfolio actions to restore long-term earnings quality.

Amcor (AMCR) vs. SPDR S&P 500 ETF (SPY)

Amcor Business Overview & Revenue Model

Company DescriptionAmcor plc develops, produces, and sells packaging products in Europe, North America, Latin America, Africa, and the Asia Pacific regions. The company operates through two segments, Flexibles and Rigid Packaging. The Flexibles segment provides flexible and film packaging products in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Rigid Packaging segment offers rigid containers for a range of beverage and food products, including carbonated soft drinks, water, juices, sports drinks, milk-based beverages, spirits and beer, sauces, dressings, spreads, and personal care items; and plastic caps for various applications. The company sells its products primarily through its direct sales force. Amcor plc was incorporated in 2018 and is headquartered in Zürich, Switzerland.
How the Company Makes MoneyAmcor generates revenue primarily through the sale of its packaging products across various sectors. The company operates in two main segments: Flexibles and Rigid Packaging. Its Flexibles segment includes products like flexible films and bags, while the Rigid Packaging segment encompasses containers and lids. Amcor's revenue model is based on long-term contracts with large multinational clients, which provides stability and predictability in earnings. Additionally, the company benefits from strategic partnerships and collaborations with key players in the food, beverage, and healthcare industries, enabling it to innovate and expand its product offerings. Factors contributing to its earnings include increased demand for sustainable packaging solutions, geographic expansion into emerging markets, and a focus on operational efficiency to reduce costs.

Amcor Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Analyzes income from different business units, highlighting which segments drive growth and profitability, and identifying areas of potential expansion or risk.
Chart InsightsRevenue mix shifted sharply in mid‑2025: rigid packaging surged and now drives most of the recent top‑line gain while flexibles show a steadier recovery. Management’s call confirms EPS and margin improvement came from cost discipline and realized synergies rather than volume growth, and volumes were down with weakness in beverage and nutrition. That implies recent revenue gains may be inorganic or reclassifications; watch integration execution, sustainability of margin expansion, and potential divestitures of weaker beverage assets.
Data provided by:The Fly

Amcor Earnings Call Summary

Earnings Call Date:Feb 03, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Positive
The call emphasized strong integration execution and accelerating synergies, delivered results in line with expectations, reaffirmed full-year EPS and free cash flow guidance, and highlighted meaningful commercial wins and balance sheet discipline. Offsetting these positives were persistent modest volume declines, short-term weak performance in a $2.5B non-core portfolio (notably North American beverage), some near-term margin and operating-leverage headwinds, and one-time integration costs. Overall, management presented confidence in mid-to-long-term value creation while acknowledging short-term market softness and non-core volatility.
Q2-2026 Updates
Positive Updates
Revenue and Profitability in Line with Expectations
Q2 revenue $5.4B, EBITDA $826M, EBIT $603M; adjusted EPS $0.86 for the quarter (adjusted EPS up 7% in Q2 and up 14% for the first half versus prior year).
Free Cash Flow and Dividend
Free cash flow of $289M in Q2 (first half cash outflow $53M, in line with expectations); Board declared quarterly dividend of $0.65 per share, up year-over-year; reaffirmed full-year free cash flow guidance of $1.8B–$1.9B.
Synergy Capture Accelerating
Synergy benefits accelerated to $55M in Q2 and totaled $93M in the first half; management reaffirmed at least $260M of synergies for fiscal 2026 and $650M through fiscal 2028; procurement target $325M by 2028.
Core Portfolio Resilience
Core portfolio (~$20B) outperformed the combined company: core volumes down ~1.5% (≈100 bps better than total portfolio) and adjusted EBIT dollars up ~7% for the core (excluding synergies, earnings broadly flat vs prior year).
Segment Performance — Rigid and Flexible
Flexible packaging sales +23% constant currency (driven by acquisition); flexible adjusted EBIT +22% cc to $402M (comparable EBIT up ~1%). Rigid adjusted EBIT $228M; on a comparable constant currency basis excluding non-core, rigid adjusted EBIT up ~15% and adjusted EBIT margin excluding non-core improved ~200 bps to ~12%.
Balance Sheet and Capital Allocation
Adjusted leverage exiting Q2 was 3.6x with expectation to end the year ~3.1–3.2x; FY capex expected $850M–$900M; commitment to maintain investment-grade rating and modestly growing dividend; first-half capex $459M.
Commercial Wins and Growth Synergies
Annualized sales from wins linked to the Berry combination now exceed $100M toward a three-year target of $280M; example win supplying blister packaging and rigid containers for a major pharmaceutical GLP-1 therapy.
Integration and Operational Progress
Over 600 headcount reductions executed consistent with integration roadmap; ~20 site closures/restructures approved/announced; early realization of G&A, procurement and financial synergies.
Negative Updates
Volume Weakness Across the Business
Total company volumes were down ~2%–2.5% in Q2 (management cited both ~2% and ~2.5% figures); flexible volumes ~2% down on a comparable basis; core volumes ~1.5% down; Europe more challenged than North America.
Non-Core Portfolio Underperformance
Non-core businesses (~$2.5B) had a difficult Q2: first-half top line roughly $1.2B with EBIT margins ~5% for H1 and Q2 margins near ~3%; non-core generated a ~ $30M year-over-year headwind in Q2 and required portfolio actions; management expects ~ $50M improvement in H2 as terms and operations normalize.
Limited Short-Term Operating Leverage
Despite acquisition-driven revenue increases, operating leverage was muted in the near term: flexible segment comparable EBIT only ~1% higher (ex-acquisition), and overall margins expected to show more multiyear improvement rather than large short-term margin expansion.
Integration and One-Time Costs
Acquisition-related cash costs funded ~$70M in the quarter; many operational synergies (site consolidations, network changes) will materialize in years two and three, implying near-term disruption and restructuring costs.
Safety Metric Slightly Worsened
Total recordable incident rate (TRIR) was 0.52 for Q2, a modest increase versus last year (company attributes some change to recent acquisition integration).
Guidance Messaging Inconsistency
Management reiterated full-year adjusted EPS and FCF guidance, but two different EPS ranges were referenced in prepared remarks ($4.20–$4.50 and $4.00–$4.15 after reverse split), which could cause short-term investor confusion.
Company Guidance
Management reaffirmed fiscal 2026 guidance, with the CFO citing full‑year adjusted EPS of $4.00–$4.15 per share (the CEO earlier referenced $4.20–$4.50 after the one‑for‑five reverse split), implying ~12%–17% YoY adjusted EPS growth; Q3 adjusted EPS was guided to $0.90–$1.00 (including ~$70–$80M of synergies). Free cash flow was reaffirmed at $1.8–$1.9B (management expects to double FCF vs. FY2025), capex is expected at $850–$900M, adjusted leverage exited Q2 at 3.6x and is expected to be ~3.1–3.2x at year end, and a $0.65 quarterly dividend was declared. Synergy targets were reiterated at at least $260M in FY2026 and $650M through FY2028 (including $325M of procurement synergies by 2028), noting Q2 synergies of $55M and $93M year‑to‑date.

Amcor Financial Statement Overview

Summary
Revenue growth is improving (+12.7% TTM), and free cash flow is a clear strength ($1.62B TTM with solid conversion vs. net income). Offsetting this, profitability has weakened materially (TTM net margin ~3.3% vs. ~5.4%–7.1% prior years) and leverage remains meaningful (debt-to-equity ~1.3x) with stepped-down returns (TTM ROE ~7.5%).
Income Statement
62
Positive
AMCR shows solid top-line momentum in TTM (Trailing-Twelve-Months) with revenue up 12.7% versus the most recent annual period. Profitability, however, has clearly compressed versus prior years: TTM gross margin is ~19.0% and net margin is ~3.3%, down materially from FY2023–FY2024 net margins (~5.4%–7.1%). Operating profitability also softened (TTM operating margin ~7.0% vs. ~9%–10% in FY2023–FY2024), suggesting higher costs and/or pricing pressure. Overall: improving growth, but weaker earnings efficiency and margin stability.
Balance Sheet
55
Neutral
Leverage remains meaningful, with debt-to-equity running around ~1.3x in the most recent periods (TTM and FY2025), which limits balance-sheet flexibility in a higher-rate environment. Return on equity has also stepped down (TTM ~7.5% vs. ~19%–26% in FY2022–FY2024), consistent with the margin pressure seen in the income statement. A positive offset is that equity and total assets are large in the latest snapshots, but the overall profile still reads as moderately leveraged with reduced returns.
Cash Flow
68
Positive
Cash generation is a relative strength. TTM (Trailing-Twelve-Months) free cash flow is ~$1.62B and slightly exceeds net income (free cash flow to net income ~1.01x), indicating good cash conversion. TTM free cash flow growth is positive (+5.5%), improving versus the slight decline reported in FY2025. The main weakness is that operating cash flow coverage is low in the provided data (around ~0.19–0.31 across periods), which suggests cash flow is not especially large relative to the referenced obligation base. Overall: healthy free cash flow and conversion, but coverage metrics point to ongoing balance-sheet sensitivity.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue19.61B15.01B13.64B14.69B14.54B12.86B
Gross Profit3.57B2.83B2.71B2.73B2.82B2.73B
EBITDA2.57B1.77B1.85B2.13B1.90B1.92B
Net Income596.00M511.00M730.00M1.05B805.00M939.00M
Balance Sheet
Total Assets37.05B37.07B16.52B17.00B17.43B17.19B
Cash, Cash Equivalents and Short-Term Investments1.06B827.00M588.00M689.00M775.00M850.00M
Total Debt16.90B15.01B7.19B7.21B6.98B6.75B
Total Liabilities25.40B25.33B12.57B12.91B13.29B12.37B
Stockholders Equity11.64B11.73B3.88B4.03B4.08B4.76B
Cash Flow
Free Cash Flow1.62B810.00M829.00M735.00M999.00M993.00M
Operating Cash Flow1.60B1.39B1.32B1.26B1.53B1.46B
Investing Cash Flow-2.41B-2.10B-476.00M-309.00M-527.00M-233.00M
Financing Cash Flow1.34B910.00M-857.00M-1.02B-891.00M-1.18B

Amcor Technical Analysis

Technical Analysis Sentiment
Positive
Last Price48.43
Price Trends
50DMA
44.39
Positive
100DMA
42.29
Positive
200DMA
42.73
Positive
Market Momentum
MACD
1.40
Positive
RSI
58.90
Neutral
STOCH
25.73
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMCR, the sentiment is Positive. The current price of 48.43 is above the 20-day moving average (MA) of 47.90, above the 50-day MA of 44.39, and above the 200-day MA of 42.73, indicating a bullish trend. The MACD of 1.40 indicates Positive momentum. The RSI at 58.90 is Neutral, neither overbought nor oversold. The STOCH value of 25.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AMCR.

Amcor Risk Analysis

Amcor disclosed 35 risk factors in its most recent earnings report. Amcor reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Amcor Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$13.15B17.9725.65%1.01%2.94%893.70%
69
Neutral
$20.63B27.0517.08%2.42%7.23%-3.88%
68
Neutral
$24.47B35.113.92%4.21%
66
Neutral
$17.67B20.1216.17%1.53%2.87%
64
Neutral
$22.25B31.677.73%6.20%28.41%-35.50%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
49
Neutral
$22.71B-6.40-24.51%4.69%33.71%-517.99%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMCR
Amcor
48.15
0.34
0.70%
BALL
Ball
66.42
15.04
29.26%
CCK
Crown Holdings
116.11
28.79
32.97%
IP
International Paper Co
42.89
-10.17
-19.17%
PKG
Packaging
231.21
26.96
13.20%
SW
Smurfit Westrock
46.82
-1.30
-2.70%

Amcor Corporate Events

Business Operations and StrategyStock Split
Amcor Completes Reverse Stock Split and Capital Structure Changes
Neutral
Jan 15, 2026

On January 14, 2026, Amcor implemented a 1-for-5 reverse stock split previously approved by shareholders on November 6, 2025, consolidating every five ordinary shares into one and reducing its outstanding share count from about 2.3 billion to roughly 461 million, while proportionately adjusting authorized ordinary and preferred share counts and increasing their par value to $0.05 per share. Effective January 15, 2026, Amcor’s ordinary shares on the NYSE and its CHESS Depositary Interests on the ASX began trading on a split-adjusted basis under existing tickers, with equity-based awards adjusted accordingly and fractional share entitlements settled in cash, a move that simplifies the capital structure and may enhance trading dynamics and perceived share value for investors.

The most recent analyst rating on (AMCR) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Amcor stock, see the AMCR Stock Forecast page.

Shareholder MeetingsStock Split
Amcor Announces Reverse Stock Split Plan
Neutral
Dec 11, 2025

On December 11, 2025, Amcor announced it will proceed with a 1-for-5 reverse stock split, effective January 14, 2026, reducing its outstanding ordinary shares from approximately 2.3 billion to 461 million. This move, approved by shareholders on November 6, 2025, aims to consolidate shares and adjust share values, impacting trading on the New York and Australian Stock Exchanges. The reverse stock split will also proportionately adjust unvested equity-based awards and ensure no fractional shares are issued, with cash payments provided instead.

The most recent analyst rating on (AMCR) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Amcor stock, see the AMCR Stock Forecast page.

Executive/Board ChangesShareholder MeetingsStock Split
Amcor Shareholders Approve Key Proposals at AGM
Neutral
Nov 10, 2025

At its Annual General Meeting on November 6, 2025, Amcor plc shareholders re-elected eleven directors and ratified PricewaterhouseCoopers AG as the independent registered public accounting firm for the 2026 fiscal year. Additionally, shareholders approved the executive compensation plan, decided on an annual advisory vote frequency for executive compensation, and sanctioned an amendment to the company’s Memorandum of Association to implement a reverse stock split. These decisions reflect a strategic alignment with shareholder interests and a focus on corporate governance, potentially impacting Amcor’s operational efficiency and market perception.

The most recent analyst rating on (AMCR) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Amcor stock, see the AMCR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 05, 2026